Bliss GVS Pharma Limited (BOM:506197)
India
· Delayed Price · Currency is INR 204.50
-9.50 (-4.44%)
At close: Mar 9, 2026
Bliss GVS Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 21,634 | 12,386 | 11,793 | 7,421 | 7,978 | 10,181 | Upgrade
|
| Market Cap Growth | 55.25% | 5.03% | 58.92% | -6.98% | -21.63% | -2.08% | Upgrade
|
| Enterprise Value | 20,511 | 11,511 | 11,487 | 7,314 | 7,890 | 10,302 | Upgrade
|
| Last Close Price | 204.50 | 116.92 | 111.56 | 70.11 | 75.21 | 96.03 | Upgrade
|
| PE Ratio | 20.07 | 14.69 | 15.63 | 10.47 | 53.05 | 14.86 | Upgrade
|
| Forward PE | - | 6.57 | 6.57 | 6.57 | 6.57 | 6.57 | Upgrade
|
| PS Ratio | 2.49 | 1.53 | 1.53 | 0.99 | 1.07 | 1.76 | Upgrade
|
| PB Ratio | 1.85 | 1.13 | 1.18 | 0.81 | 0.94 | 1.23 | Upgrade
|
| P/TBV Ratio | 1.92 | 1.19 | 1.23 | 0.85 | 0.98 | 1.27 | Upgrade
|
| P/FCF Ratio | - | 41.50 | 15.83 | - | 12.98 | 18.56 | Upgrade
|
| P/OCF Ratio | - | 11.70 | 11.47 | 21.63 | 5.89 | 15.92 | Upgrade
|
| PEG Ratio | - | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | Upgrade
|
| EV/Sales Ratio | 2.36 | 1.42 | 1.49 | 0.97 | 1.06 | 1.79 | Upgrade
|
| EV/EBITDA Ratio | 14.85 | 9.42 | 7.77 | 6.31 | 6.77 | 9.88 | Upgrade
|
| EV/EBIT Ratio | 19.02 | 11.83 | 9.25 | 7.42 | 7.79 | 11.52 | Upgrade
|
| EV/FCF Ratio | - | 38.56 | 15.42 | - | 12.83 | 18.78 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.08 | 0.10 | 0.11 | 0.13 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.38 | 0.70 | 0.66 | 0.87 | 0.92 | 1.14 | Upgrade
|
| Debt / FCF Ratio | - | 2.95 | 1.34 | - | 1.78 | 2.22 | Upgrade
|
| Net Debt / Equity Ratio | -0.13 | -0.05 | -0.04 | 0.04 | -0.03 | 0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.11 | -0.44 | -0.27 | 0.29 | -0.22 | 0.58 | Upgrade
|
| Net Debt / FCF Ratio | - | -1.78 | -0.54 | -0.56 | -0.42 | 1.10 | Upgrade
|
| Asset Turnover | - | 0.65 | 0.65 | 0.66 | 0.68 | 0.55 | Upgrade
|
| Inventory Turnover | - | 3.53 | 3.62 | 3.64 | 3.62 | 3.90 | Upgrade
|
| Quick Ratio | - | 3.45 | 3.55 | 2.38 | 2.32 | 2.66 | Upgrade
|
| Current Ratio | - | 4.81 | 5.15 | 3.61 | 3.33 | 3.76 | Upgrade
|
| Return on Equity (ROE) | - | 8.62% | 8.50% | 8.70% | 2.76% | 9.37% | Upgrade
|
| Return on Assets (ROA) | - | 4.84% | 6.56% | 5.44% | 5.79% | 5.31% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.19% | 6.98% | 9.06% | 8.05% | 5.06% | 7.37% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 8.60% | 11.80% | 10.20% | 11.60% | 10.20% | Upgrade
|
| Earnings Yield | 5.04% | 6.81% | 6.40% | 9.55% | 1.88% | 6.73% | Upgrade
|
| FCF Yield | - | 2.41% | 6.32% | -8.02% | 7.71% | 5.39% | Upgrade
|
| Dividend Yield | 0.47% | 0.43% | 0.45% | 0.71% | 0.66% | 0.52% | Upgrade
|
| Payout Ratio | - | 6.46% | 7.15% | 7.67% | 35.41% | 8.10% | Upgrade
|
| Buyback Yield / Dilution | -1.06% | 0.04% | -0.56% | -0.26% | 0.26% | -2.26% | Upgrade
|
| Total Shareholder Return | -0.59% | 0.46% | -0.11% | 0.45% | 0.93% | -1.74% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.